Cobicistat

Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Cobicistat and local guidelines before prescribing.

Pharmacokinetic booster

Mechanism

CYP3A4 inhibitor used as pharmacokinetic booster.

Uses

Boosting agent for HIV regimens.

Dosing

Side effects

Nausea, diarrhoea, raised creatinine (tubular secretion).

Interactions

Many CYP3A4 and P-gp substrates.

Contraindications and cautions

Strong CYP3A4 interacting drugs

Monitoring

Creatinine, interactions

Pregnancy and breastfeeding

Avoid in second and third trimesters

Renal and hepatic impairment

Avoid if CrCl below 70 with tenofovir disoproxil

Overdose and reversal

Supportive

Special advice

Interaction check essential.

More from the textbook: uses, cautions and other points
Where it is discussed in the book